Connecting Industries Worldwide

Chemicals and Pharmaceuticals

ExxonMobil will proceed with a $2 billion investment to expand its Baytown, Texas chemical plant, which will create approximately 2,000 jobs during construction and contribute to the approximate 15% return the company expects from its chemical investments.

Read more ...

Raytheon is developing a portable device to evaluate bacteria and their potential to cause harm—information that could support the future development of medical countermeasures and improved screening tools.

Read more ...

Nouryon has completed a €4 million expansion at Mahad, India, which will increase organic peroxides production capacity at the site by 80%.

Read more ...

Evotec SE and Indivumed have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer.

Read more ...

Novartis has completed the spin-off of the Alcon eye care devices business.

Read more ...

Nouryon has introduced a new powder version of its Perkadox 16 organic peroxide.

Read more ...

Leaps by Bayer, the investment arm of the global life sciences company Bayer, and Khloris Biosciences, a biotechnology company, have joined forces to develop novel, first-in-class anti-cancer vaccines based on human induced pluripotent stem cells.

Read more ...

AveXis, a Novartis company, has signed an agreement to purchase an advanced biologics therapy manufacturing campus in Longmont, Colorado.

Read more ...